-
EP4225761
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4225761
| EP4225761 - MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.07.2023 Database last updated on 14.11.2024 | |
| Former | The international publication has been made Status updated on 16.04.2022 | ||
| Former | unknown Status updated on 15.11.2021 | Most recent event Tooltip | 28.10.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston, MA 02210 / US | [2023/33] | Inventor(s) | 01 /
McCARTNEY, Jason Boston, Massachusetts 02210 / US | 02 /
ABELA, Alexander Russell Boston, Massachusetts 02210 / US | 03 /
ABRAHAM, Sunny Boston, Massachusetts 02210 / US | 04 /
ANDERSON, Corey Don Boston, Massachusetts 02210 / US | 05 /
ARUMUGAM, Vijayalaksmi Boston, Massachusetts 02210 / US | 06 /
CHAU, Jaclyn Boston, Massachusetts 02210 / US | 07 /
CLEMENS, Jeremy Boston, Massachusetts 02210 / US | 08 /
CLEVELAND, Thomas Boston, Massachusetts 02210 / US | 09 /
COON, Timothy Richard Boston, Massachusetts 02210 / US | 10 /
DWIGHT, Timothy A. Boston, Massachusetts 02210 / US | 11 /
FRIEMAN, Bryan A. Boston, Massachusetts 02210 / US | 12 /
GROOTENHUIS, Peter (Deceased) / US | 13 /
HADIDA RUAH, Sara Sabina Boston, Massachusetts 02210 / US | 14 /
ISHIHARA, Yoshihiro Boston, Massachusetts 02210 / US | 15 /
KHATUYA, Haripada Boston, Massachusetts 02210 / US | 16 /
KRENITSKY, Paul Boston, Massachusetts 02210 / US | 17 /
MILLER, Mark Thomas Boston, Massachusetts 02210 / US | 18 /
PARASELLI, Prasuna Boston, Massachusetts 02210 / US | 19 /
PIERRE, Fabrice Boston, Massachusetts 02210 / US | 20 /
SILINA, Alina Boston, Massachusetts 02210 / US | 21 /
TRAN, Joe A. Boston, Massachusetts 02210 / US | 22 /
ZHOU, Jinglan Boston, Massachusetts 02210 / US | [2023/33] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2023/33] | Application number, filing date | 21801353.0 | 06.10.2021 | [2023/33] | WO2021US53855 | Priority number, date | US202063088759P | 07.10.2020 Original published format: US 202063088759 P | [2023/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022076620 | Date: | 14.04.2022 | Language: | EN | [2022/15] | Type: | A1 Application with search report | No.: | EP4225761 | Date: | 16.08.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.04.2022 takes the place of the publication of the European patent application. | [2023/33] | Search report(s) | International search report - published on: | EP | 14.04.2022 | Classification | IPC: | C07D515/04, A61P43/00, A61K31/519 | [2023/33] | CPC: |
C07D515/04 (EP);
C07D515/08 (US);
A61K31/529 (US);
A61K31/5377 (US);
A61K45/06 (US);
A61P43/00 (EP);
C07D515/18 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/33] | Title | German: | MODULATOREN DES REGULATORS DER TRANSMEMBRAN-LEITFÄHIGKEIT BEI ZYSTISCHER FIBROSE | [2023/33] | English: | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | [2023/33] | French: | MODULATEURS DU RÉGULATEUR DE LA CONDUCTANCE TRANSMEMBRANAIRE DE LA FIBROSE KYSTIQUE | [2023/33] | Entry into regional phase | 03.05.2023 | National basic fee paid | 03.05.2023 | Designation fee(s) paid | 03.05.2023 | Examination fee paid | Examination procedure | 03.05.2023 | Examination requested [2023/33] | 03.05.2023 | Date on which the examining division has become responsible | 30.11.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 03.05.2023 | Renewal fee patent year 03 | 28.10.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]WO2019161078 (VERTEX PHARMA [US]) [I] 1-27* example - *; | [XP]WO2020206080 (VERTEX PHARMA [US]) [XP] 1-27 * example -; claim - *; | [IP]WO2021030552 (VERTEX PHARMA [US]) [IP] 1-27 * example -; claim - * | by applicant | WO2006002421 | WO2007056341 | WO2007079139 | US2009131492 | WO2009073757 | WO2009076142 | WO2010019239 | WO2010037066 | WO2010053471 | WO2010108162 | WO2011119984 | WO2011127421 | WO2011133751 | WO2011133951 | WO2012158885 | WO2014071122 | WO2014078842 | US8865902 | WO2015160787 | - CUTTING, G. R et al., Nature, (19900000), vol. 346, pages 366 - 369 | - DEAN, M. et al., Cell, (19900000), vol. 61, no. 863, page 870 | - KEREM, B-S et al., Science, (19890000), vol. 245, pages 1073 - 1080 | - KEREM, B-S et al., Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 8447 - 8451 | - QUINTON, P. M., FASEB J, (19900000), vol. 4, pages 2709 - 2727 | - DALEMANS et al., Nature Lond, (19910000), vol. 354, pages 526 - 528 | - PASYKFOSKETT, J. Cell. Biochem., (19950000), vol. 270, pages 12347 - 50 | - S. M. BERGE et al., J. Pharmaceutical Sciences, (19770000), vol. 66, pages 1 - 19 |